Medex
This article was originally published in The Gray Sheet
Executive Summary
Recent management changes include departures of Thomas Frank, who has resigned as VP of corporate R&D, and Francis Griffin, VP of international development. Frank's position is being filled by Dennis Tomisake, director of R&D; Griffin's replacement has not been announced. In addition, Robert Durbin, chief financial officer, is retiring early as of Sept. 30. The firm says it expects to select a new CFO in September.